Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINT: Preoperative Immunonutrition in IBD Surgery
NCT03333148Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2020
- Primary completion
- Jun 2021
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Occurrence of any postoperative complications at 60 days. Planned start Jun 2020; status: withdrawn.
Beyond the preview
Go deeper on NCT03333148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333148.